Both public sector agencies and private sector investors are pouring new money into the synthetic biology space, and that’s leading to a situation where we can expect a burst of new innovations impacting fields as diverse as agriculture, energy and health. According to the latest...
Shares of Exact Sciences Corp. plunged Tuesday morning after the U.S. Preventive Services Task Forceissued a preliminary recommendation, saying it considers the company's non-invasive colon cancer test as an "alternative test." The Madison company's stock dropped more than 40% in morning trading. The shares, which closed...
In April 2015, a paper by Chinese scientists about their attempts to edit the DNA of a human embryo rocked the scientific world and set off a furious debate. Leading scientists warned that altering the human germ line without studying the consequences could have horrific...
From the “be careful what you wish for” file ...
Promega Corp., one of the Madison area’s most successful, homegrown and fiercely independent biotechnology companies, is in the midst of a hostile takeover attempt by two shareholders who want to buy a majority of shares and boot Promega’s founder and CEO Bill Linton....
'Patients can actually begin to care for themselves – relieve the burden of the delivery system and get a better result' For those healthcare providers still resistant to technology, you've got a problem on your hands: You're going to be left behind. This is where healthcare...
Steve Pitstick has been farming for 42 years. He grows corn and soybean in Illinois. Pitstick, who has always been tech savvy, recalls using PC cards to transport data from his farming equipment to his beige PC. As the digital revolution has unfolded, Pitstick has watched...
Lockheed Martin made several forays into healthcare last year, buying small, specialized companies. But the defense giant’s latest move in this space is its most personal yet. Lockheed and San Diego company Illumina are teaming up to study the human genome — the stuff that makes you...
Thirty years ago, a smart young entrepreneur stood up in front of a group of investors at the first Madison Venture Fair to talk about a company that was selling molecular biological products, such as enzymes and nucleic acids, to researchers and laboratories. That company...
BioForward has named Laura Bray its new CEO, the Madison organization representing Wisconsin's biotechnology companies announced Wednesday. Bray has served the past 10 years as executive director of Menomonee Valley Partners Inc., a public-private partnership advocating economic development and ecological restoration in Milwaukee's Menomonee River...